My apologies if this document has been mentioned and posted by someone before.
I came across it this morning while doing some research.
I don't recall seeing it before.
The Next Generation of Rare Disease Drug Policy Ensuring Both Innovation and Affordability
7 April 2022
https://icer.org/wp-content/uploads/2022/04/ICER-White-Paper_The-Next-Generation-of-Rare-Disease-Drug-Policy_040722.pdf
Extracts from page 19 onwards:
Noting:
"While orphan products range widely in price, a small proportion carry an extremely high price,
usually linked to very small (e.g. < 10,000) eligible patients. Research shows that orphan drugs
costing over $500,000 per year represent 5% of all orphan drugs and treat 0.08% of patients taking
orphan medications (ref 85)."
Here is the document referred to as Reference 85:
https://rarediseases.org/wp-content/uploads/2021/03/orphan-drugs-in-the-united-states-NRD-2020.pdf
GLTAHs
- Forums
- ASX - By Stock
- NEU
- Trof Pricing - name your price
Trof Pricing - name your price, page-21
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.72 |
Change
-0.150(0.72%) |
Mkt cap ! $2.648B |
Open | High | Low | Value | Volume |
$20.96 | $21.28 | $20.61 | $4.984M | 239.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 782 | $20.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.72 | 1021 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3 | 20.630 |
1 | 500 | 20.620 |
1 | 300 | 20.600 |
1 | 145 | 20.550 |
1 | 213 | 20.530 |
Price($) | Vol. | No. |
---|---|---|
20.600 | 268 | 1 |
20.700 | 300 | 2 |
20.720 | 676 | 1 |
20.940 | 114 | 1 |
21.000 | 3450 | 4 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online